OA 16.04 Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC PatientsD. Yue,Shidong Xu,Qun Wang,Xia Li,Y. Shen,Heng Zhao,Chun Chen, W. Mao,Wei Liu,Jun O. Liu,L. Zhang,H. Ma,Q. Li,Yu Yang,Y. Liu,Hongyan Chen,C. WangJOURNAL OF THORACIC ONCOLOGY(2017)引用 3|浏览26暂无评分关键词Adjuvant therapy,Erlotinib,EGFR mutationAI 理解论文溯源树样例生成溯源树,研究论文发展脉络